![Mersana Therapeutics, Inc. [MRSN] reports annual net loss of $171,670,000.0](/_next/image?url=https%3A%2F%2F10kinfo-appdata.s3.us-west-2.amazonaws.com%2Fedgar0105%2FCompanyLogos%2FUS%2FMRSN.png&w=3840&q=75)
Mersana Therapeutics, Inc. [MRSN] reports annual net loss of $171,670,000.0
Company Reports Revenue of $36.9 million
By USInMinutes
Published - Feb 29, 2024, 05:46 AM ET
Last Updated - Feb 29, 2024, 05:46 AM EST
Mersana Therapeutics, Inc. [MRSN] has reported a net loss of $171,670,000.0 for year ended Dec 31, 2023.
The Company said in a filing before the Securities and Exchange Commission that its total revenue for the year was $36.9 million
Based in CAMBRIDGE, Massachusetts, Mersana Therapeutics, Inc. operates in the MANUFACTURING sector.
In the Consolidated Statements of Operations and Comprehensive Loss for the 12 Months Ended December 31 of the years 2023, 2022, and 2021, the following financial data was reported:
Collaboration revenue amounted to $36.855 million in 2023, increasing from $26.581 million in 2022 and $43,000 in 2021.
